R2G Launches a New Global Annual Survey: Global Digital Health Business Outlook - 2022

R2G launches a new Global Annual Digital Health Business Survey - 2022 to assess the digital health industry outlook in 2022. The survey is conducted by R2G on an on-going basis annually which focuses on gathering opinions from digital health decision makers on how the digital health industry will evolve in the coming year.

The global annual digital health business survey - 2022 will shed light on the digital health business outlook in the upcoming year. Share your views with us and help us predict what 2022 would bring to the digital health industry in terms of investments, funding, business potential, and key trends in the industry.

The survey aims to answer the following questions:

  • Which countries will have the biggest business potential in 2022?
  • Which are the most successful business models and digital health solution types that will represent the highest business potential?
  • Which trends will drive the digital health market?
  • Will the funds and investments keep on rising?
  • and more

R2G's market study participants will include digital health industry decision makers from digital health companies and start-ups, pharma, insurance, med-tech, hospitals, and public authorities.

The survey will be open until 26th January 2022.

Do you want your voice to be heard? You are invited to test your thoughts and compare your ideas with other industry representatives.

Take part in the R2G's Global annual digital health business survey 2022 and:

  • Provide your thoughts and opinion on the rapidly evolving digital health industry.
  • Have your say on what will be the trends and predicted outlook in the digital health industry for 2022.
  • Receive a summary of the results & learn from the opinions of other participants.

Your opinion and contribution matter!

For further information and Global Digital Health Business Outlook - 2022 survey, please visit:
https://bit.ly/3KCdWvD

About R2G

R2G exists to support business in digital healthcare and ultimately improve the way healthcare services are delivered globally.

We do this by providing market and competitor insights (research) and strategy advice (guidance). We facilitate partnerships creation between best-in-class innovators and established healthcare companies and help them to align their service offerings and business models.

We thrive for excellence in all we do. Our consultants are 100% dedicated to digital health.

Based in Berlin, we work on projects around the world. We support traditional healthcare companies like pharmaceutical, health insurance or med-tech companies, medical institutions, as well as start-ups and enterprises that want to enter the healthcare market by using digital enabled business models and solutions.

Our "mHealth Developer Economics" research program and panel are the largest of its kind across the global digital health industry. It tracks the current market status and examines progression of trends since 2010. To give something back to the growing digital health business community, we share results of the research program in our yearly publications.

Since 2010, we have empowered digital health innovators and supported their missions for better healthcare.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...